Department of Molecular Microbiology, Graduate School of Medicine and Dental Science, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Front Cell Infect Microbiol. 2022 Aug 2;12:911911. doi: 10.3389/fcimb.2022.911911. eCollection 2022.
Ciprofloxacin (CIP) is a commonly used antibiotic for meningococcal chemoprophylaxis, and the mutations in the quinolone resistance-determining region of are associated with CIP-resistant . Here, we established a mismatched PCR-restriction fragment length polymorphism (RFLP) assay to detect a mutation at codon 91 of , followed by high-level CIP-resistant meningococci. We designed PCR-RFLP primers to detect the T91I mutation in by introducing an artificial I cleavage site. This assay was performed using 26 strains whose sequences have been characterized. The amplified 160 bp PCR product from was digested into three fragments (80, 66, and 14 bp) when there was no mutation, or two fragments (146 and 14 bp) when there was a mutation at codon 91. A correlation was observed between the mismatched PCR-RFLP assay and sequencing. This rapid, simple, and accurate assay has the potential to detect CIP-resistant in clinical microbiology laboratories, contributing to the appropriate antibiotic selection for meningococcal chemoprophylaxis, will help maintain an effective treatment for close contacts of IMD patients, and prevent the spread of CIP-resistant .
环丙沙星(CIP)是一种常用于脑膜炎球菌化学预防的抗生素,而 喹诺酮类药物耐药决定区的突变与 CIP 耐药有关。在这里,我们建立了一种错配 PCR-限制性片段长度多态性(RFLP)检测方法,以检测 中密码子 91 的突变,随后是高水平的 CIP 耐药脑膜炎球菌。我们设计了 PCR-RFLP 引物,通过引入人工 I 切割位点来检测 中的 T91I 突变。该检测使用 26 株已鉴定其 序列的菌株进行。当没有突变时,从 扩增的 160 bp PCR 产物被切割成三个片段(80、66 和 14 bp),或者当密码子 91 发生突变时,被切割成两个片段(146 和 14 bp)。错配 PCR-RFLP 检测与 测序之间存在相关性。这种快速、简单和准确的检测方法有可能在临床微生物学实验室中检测到 CIP 耐药 ,有助于为脑膜炎球菌化学预防选择合适的抗生素,有助于维持对 IMD 患者密切接触者的有效治疗,并防止 CIP 耐药的传播。